AGRONOMICS LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 8.4 GBX | +5.00% |
|
+7.97% | -11.58% |
| Apr. 26 | Agronomics investee raises additional EUR8 million | AN |
| Apr. 26 | Agronomics' Portfolio Company Raises Additional EUR8 Million for New Protein Product | MT |
| Sales 2022 | 6.42M 8.02M | Sales 2023 | 29.7M 37.1M | Capitalization | 104M 129M |
|---|---|---|---|---|---|
| Net income 2022 | 8M 9.99M | Net income 2023 | 22M 27.48M | EV / Sales 2022 | 1.58 x |
| Net cash position 2022 | 146M 183M | Net cash position 2023 | 170M 212M | EV / Sales 2023 | -2.23 x |
| P/E ratio 2022 |
17.6
x | P/E ratio 2023 |
4.73
x | Employees | - |
| Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 83.97% |
More Fundamentals
* Assessed data
More news
| 1 day | +5.00% | ||
| 1 week | +7.97% | ||
| Current month | -4.55% | ||
| 1 month | -2.78% | ||
| 3 months | -17.24% | ||
| 6 months | -7.18% | ||
| Current year | -11.58% |
1 week
7.70
8.40
1 month
7.388.80
Current year
7.3814.50
1 year
7.3814.50
3 years
7.3841.50
5 years
4.1041.50
10 years
3.0041.50
| Managers | Title | Age | Since |
|---|---|---|---|
Denham Eke
DFI | Director of Finance/CFO | 73 | 12-05-29 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Jim Mellon
FOU | Founder | 68 | 11-05-02 |
Richard Reed
BRD | Director/Board Member | 51 | 19-05-30 |
David Giampaolo
BRD | Director/Board Member | 65 | 19-05-30 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-26 | 8.4 | +5.00% | 1,211,085 |
| 24-04-25 | 8 | +1.27% | 2,050,667 |
| 24-04-24 | 7.9 | +1.28% | 1,310,065 |
| 24-04-23 | 7.8 | 0.00% | 1,117,263 |
| 24-04-22 | 7.8 | +0.26% | 1,639,178 |
Delayed Quote London S.E., April 26, 2024 at 11:35 am EDT
More quotes
Agronomics Limited is an Isle of Man-based company that is engaged in the field of a cellular agriculture company. The Company operates in the nascent industry of modern foods, which are environmentally friendly alternatives to the traditional production of meat and plant-based sources. It seeks to secure stakes in companies owning technologies with intellectual property that offer new ways of producing food and materials with a focus on products historically derived from animals. These technologies offer solutions to enhance sustainability, as well as address human health, animal welfare, and environmental damage.
Calendar
2024-12-16
- Q4 2024 Earnings Release (Projected)
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.084
GBP
Average target price
0.1825
GBP
Spread / Average Target
+117.26%
Chiffre d''affaires - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -11.58% | 106M | |
| +31.41% | 12.02B | |
| +14.40% | 3.06B | |
| +2.96% | 1.42B | |
| +1.15% | 616M | |
| +35.79% | 577M | |
| -10.84% | 579M | |
| -4.17% | 492M | |
| +33.85% | 488M | |
| +3.90% | 304M |
- Stock Market
- Equities
- PEBI Stock
